Marina Caskey, MD
The Rockefeller University
8
7
7
N/A
0
9
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+3 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (8)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
General Manager
Tanabe Pharma Corporation
Shared therapeutic areas:
Eric Bellissant, MD, PhD
Rennes University Hospital
Shared therapeutic areas:
Paolo Bonato, PhD
Spaulding Rehabilitation Hospital
Shared therapeutic areas:
Herbert B Slade, MD
Healthpoint
Shared therapeutic areas:
emilie garrido pradalie
APHM
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
James C Eisenach, MD
Wake Forest University Health Sciences
Shared therapeutic areas:
Suman Sheraz, PhD*
Riphah International University
Shared therapeutic areas:
Lorenzo Berra, MD
Massachusetts General Hospital
Shared therapeutic areas:
Jack A Yanovski, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (8)
Showing 8 of 8 trials
HepB mAb19 in Individuals With Chronic Hepatitis B Infection
3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)
First-in-human Study of 10-1074-LS Alone and in Combination With 3BNC117-LS
3BNC117 and 10-1074 in ART-treated Individuals
3BNC117-LS First-in-Human Phase 1 Study
3BNC117 Monoclonal Antibody in HIV-infected Subjects During Treatment Interruption
Polyinosinic-Polycytidylic Acid-poly-L-lysine Carboxymethylcellulose (Poly-ICLC) in Healthy Volunteers
A Study of the Safety and Antiretroviral Activity of 3BNC117
All 8 trials loaded